Bone marrow granulomas and neutropenia associated with procainamide. Report of a case.
Bone marrow granulomas and neutropenia occurred in a 77-year-old man following the ingestion of procainamide hydrochloride for 50 days. Although neutropenia has occasionally occurred following procainamide therapy, granulomas in the bone marrow have not previously been associated with the use of this drug. There was no other apparent agent that could have been responsible for the granulomas. Eighteen days after administration of the drug had been discontinued, the WBC count returned to normal and there were no granulomas present in the bone marrow.
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D006099:Granuloma / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D011342:Procainamide / Q000009:adverse effects*
D011342:Procainamide